Literature DB >> 21971518

Glucocorticoid receptors in human epicardial adipose tissue: role of coronary status.

A Silaghi1, H Silaghi, T Scridon, R Pais, V Achard.   

Abstract

BACKGROUND: Epicardial adipose tissue (EAT) is in close contact with coronary vessels and therefore could alter coronary homeostasis. Glucocorticoids are pathophysiological mediators of visceral fat deposition and its associated atherogenic complications. AIM: We investigated in EAT the expression of the glucocorticoid receptor (GR) and its various (A, B, C) promoters.
MATERIALS AND METHODS: Paired subcutaneous adipose tissue (SAT) and EAT biopsies were obtained from 15 patients with coronary artery disease (CAD) and 12 patients without CAD (NCAD). GR and 11β-hydroxysteroid dehydrogenase type 1 protein (11β-HSD-1, the enzyme which converts inactive cortisone into active cortisol) were studied by immunohistochemistry and GR and its various promoters were studied by mRNA quantitative RT-PCR.
RESULTS: GR and 11β-HSD-1 protein were expressed in adipocytes, stromal areas, isolated stromal cells close to adipocytes, and blood vessels. Total GR mRNA levels did not differ in SAT obtained from NCAD or CAD patients and were decreased in EAT, irrespectively of the coronary status, with parallel changes in promoter B- and C-, but not promoter A-associated transcripts. Total GR mRNA and adipocyte surface in EAT obtained from CAD patients were correlated negatively (p<0.035, r=0.39).
CONCLUSIONS: Our findings demonstrate that in EAT, GR gene promoters could play a role in tissue- specific GR expression levels. EAT may be less sensitive to glucocorticoids than SAT, preventing the EAT mass development in CAD patients and suggesting a protective role on coronary homeostasis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21971518     DOI: 10.3275/7969

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  36 in total

1.  Association of coronary artery disease with glucocorticoid receptor N363S variant.

Authors:  Ruby C Y Lin; Xing Li Wang; Brian J Morris
Journal:  Hypertension       Date:  2003-02-10       Impact factor: 10.190

2.  Increased in vivo regeneration of cortisol in adipose tissue in human obesity and effects of the 11beta-hydroxysteroid dehydrogenase type 1 inhibitor carbenoxolone.

Authors:  Thekkepat C Sandeep; Ruth Andrew; Natalie Z M Homer; Robert C Andrews; Ken Smith; Brian R Walker
Journal:  Diabetes       Date:  2005-03       Impact factor: 9.461

3.  11beta-hydroxysteroid dehydrogenase type 1 mRNA is increased in both visceral and subcutaneous adipose tissue of obese patients.

Authors:  Raoul Desbriere; Vincent Vuaroqueaux; Vincent Achard; Sandrine Boullu-Ciocca; Martin Labuhn; Anne Dutour; Michel Grino
Journal:  Obesity (Silver Spring)       Date:  2006-05       Impact factor: 5.002

4.  Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction.

Authors:  Gianluca Iacobellis; Filippo Assael; Maria Cristina Ribaudo; Alessandra Zappaterreno; Giuseppe Alessi; Umberto Di Mario; Frida Leonetti
Journal:  Obes Res       Date:  2003-02

5.  Thiazolidinediones and glucocorticoids synergistically induce differentiation of human adipose tissue stromal cells: biochemical, cellular, and molecular analysis.

Authors:  Y D Halvorsen; A Bond; A Sen; D M Franklin; Y R Lea-Currie; D Sujkowski; P N Ellis; W O Wilkison; J M Gimble
Journal:  Metabolism       Date:  2001-04       Impact factor: 8.694

6.  Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease.

Authors:  Gianluca Iacobellis; Daniela Pistilli; Marco Gucciardo; Frida Leonetti; Fabio Miraldi; Gianluca Brancaccio; Pietro Gallo; Cira Rosaria Tiziana di Gioia
Journal:  Cytokine       Date:  2005-03-21       Impact factor: 3.861

Review 7.  Does altered glucocorticoid homeostasis increase cardiovascular risk?

Authors:  John P Girod; Daniel J Brotman
Journal:  Cardiovasc Res       Date:  2004-11-01       Impact factor: 10.787

8.  Expression of adrenomedullin in human epicardial adipose tissue: role of coronary status.

Authors:  Alina Silaghi; Vincent Achard; Odile Paulmyer-Lacroix; Traian Scridon; Virginie Tassistro; Ileana Duncea; Karine Clément; Anne Dutour; Michel Grino
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-09-18       Impact factor: 4.310

9.  Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians.

Authors:  Robert S Lindsay; Deborah J Wake; Saraswathy Nair; Joy Bunt; Dawn E W Livingstone; Paska A Permana; P Antonio Tataranni; Brian R Walker
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

10.  Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome.

Authors:  David P Macfarlane; Shareen Forbes; Brian R Walker
Journal:  J Endocrinol       Date:  2008-05       Impact factor: 4.286

View more
  4 in total

Review 1.  Effects of cocaine on the hypothalamic-pituitary-adrenal axis.

Authors:  L Manetti; F Cavagnini; E Martino; A Ambrogio
Journal:  J Endocrinol Invest       Date:  2014-05-23       Impact factor: 4.256

2.  The role of mediastinal adipose tissue 11β-hydroxysteroid d ehydrogenase type 1 and glucocorticoid expression in the development of coronary atherosclerosis in obese patients with ischemic heart disease.

Authors:  Fatmahan Atalar; Selcuk Gormez; Baris Caynak; Gokce Akan; Gamze Tanriverdi; Sema Bilgic-Gazioglu; Demet Gunay; Cihan Duran; Belhhan Akpinar; Ugur Ozbek; Ahmet Sevim Buyukdevrim; Zeliha Yazici
Journal:  Cardiovasc Diabetol       Date:  2012-09-25       Impact factor: 9.951

Review 3.  Transcriptome and Molecular Endocrinology Aspects of Epicardial Adipose Tissue in Cardiovascular Diseases: A Systematic Review and Meta-Analysis of Observational Studies.

Authors:  Zhila Maghbooli; Arash Hossein-Nezhad
Journal:  Biomed Res Int       Date:  2015-11-09       Impact factor: 3.411

4.  Fat Cell Size: Measurement Methods, Pathophysiological Origins, and Relationships With Metabolic Dysregulations.

Authors:  Run Zhou Ye; Gabriel Richard; Nicolas Gévry; André Tchernof; André C Carpentier
Journal:  Endocr Rev       Date:  2022-01-12       Impact factor: 19.871

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.